Adaptive Biotechnologies President and COO Julie Rubinstein Sells $1.05M of Stock
Julie Rubinstein, President and COO, sold 35,228 shares of Adaptive Biotechnologies Corp at $28.93 to $31.22 a share (average $29.73) in 4 transactions, worth $1.05M in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 377,802 (-2.9%).
Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky Sells $60K of Stock
Susan Bobulsky, Chief Commercial Officer, MRD, sold 1,875 shares of Adaptive Biotechnologies Corp at $32.00 a share, worth $60K in total on Nov 11, 2026. Shares held after the trade: 387,475 (-0.5%).
Adaptive Biotechnologies President and COO Julie Rubinstein Sells $709K of Stock
Julie Rubinstein, President and COO, sold 23,762 shares of Adaptive Biotechnologies Corp at $28.87 to $30.58 a share (average $29.82) in 5 transactions, worth $709K in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 377,802 (-0.5%).